responsible for curadigm's core business area - data digitization services includes curation and data annotation; working across the industries on big data challenges, including pharma, biotech, academics, FMCG, Consumer companies, primarily focusing on scientific , research projects, data digitization, and offering high quality data (training data) for AI/ML companies. Responsible for curadigm's business development and strategic operations. Working on expanding strategic collaboration and partnerships across the territories such as Japan, S.Korea, Europe, USA and so on. Curadigm's core services on Data Digitization Services includes Data Curation | Data Annotation | Data Integration | Data Validation | Data Interpretation - www.curadigmdata.com

responsible for the key segment of Excelra Business - Biology Vertical, includes world renowned GOBIOM Biomarker Database and the Biology Custom Services. key responsibilities include overall P&L of Biology Vertical; development of integrated growth strategies to increase the custom service offerings and revenue; revamp of GOBIOM Biomarker Database, product development, including the detailed analysis of the existing product across the technology, target audience, coverage of information, market segments, recent trends in biomarkers and genomics etc., restructuring the biomarker curation platform, technology, advanced analytics, features and functionalities to bring customer driven robust platform to derive meaningful insights. responsible for the curation operations involving data extraction from primary literatures, clinical trials, diagnostics and regulatory documents etc. Strategic preparation of use cases / business cases; go to market; branding, market reach. establishing the innovation pipeline of new capabilities and proposals to enhance the service offerings across diversified life science segments. working closely with distributors, and identification of new distributors to reach the untapped market in APAC region.

We leverage our expertise to the discovery research challenges through our diversified custom services. Our research services provide customised and structured delivery of information for life science, pharmaceutical, clinical diagnostics, and biotech companies; academic institutes to find solutions for their discovery research and development.

responsible for the global curation operations; involving India, Germany and USA Curation groups. Curation platform infrastructure; productivity, quality metrics, handling of core scientific projects across diversified disciplines including pathways, functional annotation of proteins and genes, disease markers, genetic variations and phenotypes/diseases, pharmacogenomics, drug-target-disease relationships; worked closely with internal product managers, as well as external customers (clients). Managed both product and customer driven content management projects such as,- Proteome, Transpath, Transfac, PGMD, IPA - RNASeq, Clinical Insight (Product driven content and knowledge management projects )- NGS clinical data curation, Genetic variation- Phenotype reporting, PGx curation, Clinical actionable reportings, Pathway curation, simulation of pathways and networks, drug adverse effects curation, protein - protein interaction, vocabulary and ontology standardization, patent curation, enzyme kinetics, metabolic pathways and networks; gene expression data analysis, NGS data analysis, variant calling and mapping of functional significance etc., (Customer driven content and knowledge management offerings)Responsible for Custom service businessResponsible for distributor relationships and business in China, Japan, Australia, S. KoreaAs a senior member of the management team, facilitated the successful M&A with QIAGEN; driving the smooth integration of BIOBASE curation and knowledge management process into QIAGEN's BB unit.

Metabolic Pathways (aMAZE project) funded by the Ministry of Bruxelles RegionP53-MDM2 Network (COMBIO project) funded by European Union Frame Work (FP5)